Current news for MSLP, NATR, and REED

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) August 27, 2010 -- crwefinancelogo2

signup3m

MusclePharm Corporation (OTC:MSLP) recently reported that the National Association of People with AIDS requests the approval of MSLP’s Recon nutritional supplement to the New York State Medicaid list of prescription medications. MSLP’s nutritional supplement Recon contains important amino acids that help assist in reaching higher levels of nutrition for pepople living with HIV. MSLP’s easily digestable supplement helps the absorption of amino acids and proteins, it also contains essential minerals, Glutamine, and digestive enzymes along with other metabolic agents that help maximize recovery, protein synthesis and endurance.

MSLP is a fast-growing developer and manufacturer of safe, scientifically approved nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists.

Nature’s Sunshine Products, Inc. (NASDAQ:NATR), a leading manufacturer and marketer of nutritional supplements and complementary products recently reported that Candace K. Weir has resignated from the companys board of directors. At the same time, the Company announced the appointment of Robert Mercer, an executive with 33 years in law and business, as a member of the Board of Directors, to serve as a Class II director and as a member of the Audit Committee. Weir was originally appointed to the Board in 2009 as a Class II director. She was later elected by the Company’s shareholders to this same position during the 2009 Annual Meeting.

NATR manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, the Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic, the Netherlands, and Vietnam. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.





Reed’s, Inc. (NASDAQ:REED) is the maker of the top selling sodas in natural food stores nation wide. REED recently reported that Publix Super Markets, which operates 1020 supermarkets in Florida, Georgia, South Carolina, Alabama, and Tennessee, will begin carrying Reed’s Natural Ginger Nausea Relief, a ginger-based remedy for nausea and motion sickness, in the over-the-counter remedy aisle in all of Publix locations.

REED makes the top selling natural sodas in the natural foods industry sold in over 10,500 natural food markets and supermarkets nationwide. In 2009, Reed’s started producing Private Label natural beverages for select national chains. Its six award-winning non-alcoholic Ginger Brews are unique in the beverage industry, being brewed, not manufactured and using fresh ginger, spices and fruits in a brewing process that predates commercial soft drinks. The Company owns the top selling root beer line in natural foods, the Virgil’s Root Beer product line, and the top selling cola line in natural foods, the China Cola product line.











http://crwefinance.com/img/crwefinance_new_buscard2.jpg

Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).